Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
Medtronic
Queensland Health
Cerilliant
Mallinckrodt
Federal Trade Commission
Moodys
Julphar
US Army

Generated: October 18, 2017

DrugPatentWatch Database Preview

ELMIRON Drug Profile

« Back to Dashboard

Which patents cover Elmiron, and what generic Elmiron alternatives are available?

Elmiron is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in ELMIRON is pentosan polysulfate sodium. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentosan polysulfate sodium profile page.

Summary for Tradename: ELMIRON

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list7
Clinical Trials: see list5
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ELMIRON at DailyMed

Pharmacology for Tradename: ELMIRON

Ingredient-typeGlycosaminoglycans
Drug ClassGlycosaminoglycan
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
ELMIRON
pentosan polysulfate sodium
CAPSULE;ORAL020193-001Sep 26, 1996RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ELMIRON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
ELMIRON
pentosan polysulfate sodium
CAPSULE;ORAL020193-001Sep 26, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Express Scripts
Farmers Insurance
Queensland Health
UBS
Daiichi Sankyo
Citi
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot